UK: Queen’s Park Equity closes Fund II £305m

Queen’s Park Equity (QPE) has announced the close of its second fund, QPE Fund II at £305m (US$395m) - a 50% increase on QPE Fund I from December...

Switzerland: 65 Equity Partners backs HAS acquisition of Cerbios-Pharma

Full service CDMO HAS Healthcare Advanced Synthesis, an international developer and producer of active pharmaceutical ingredients (APIs), high-potency active pharmaceutical ingredients (HPAPIs), and anticancer...

UK: CBPE announces first and final close of Fund XI at £714m hard cap

CBPE Capital, a UK mid-market private equity firm, has closed its latest fund (CBPE Fund XI) at its hard cap of £714m (US$925m). The...

Japan: Topcon accelerating growth through MBO with KKR and JIC Capital

TSE-listed Topcon Corporation, a Japanese technology company specializing in optical, surveying, and precision positioning equipment, as well as healthcare and smart infrastructure solutions. is...

This week at Novo Holdings: Backing breakthrough life science innovation

Novo Holdings has had a busy week, co-leading and participating in major financing rounds across diverse areas of the life sciences industry. From cardiovascular...

The Netherlands: Colesco provides unitranche loan to Ace Pharma

Direct lender, Colesco, has provided financing to Netherlands-based Ace Pharmaceuticals, an independent pharmaceutical company specialising in niche medical need products. The unitranche loan provided by...

UK: Kelso secures acquisition funding as it pursues growth across UK and Europe

Kelso Pharma, the Apposite Capital-backed specialty pharma, has secured over £140m of acquisition funding, a proportion of which was used by Kelso in its...

Sweden: Asker Healthcare shares rise in price on first day of trading

Shares of Asker Healthcare Group, a provider of medical products and solutions in Europe, have begun trading on Nasdaq Stockholm following its IPO, rising...

UK: THG raises £90m with founder and CEO contributing £60m

THG has raised £90m (US$116m) from new and existing shareholders, including a £60m contribution from the firm’s founder and CEO Matthew Moulding. The equity contribution is comprised...

UAE: XRP Healthcare brings forward listing plans to Q3 2025

XRP Healthcare, an AI-driven healthcare and M&A platform, built on the XRPL, dedicated to consolidating and modernizing healthcare systems across emerging markets, starting in Africa,...
Advertisement